cb1 receptor antagonist
Recently Published Documents


TOTAL DOCUMENTS

166
(FIVE YEARS 12)

H-INDEX

45
(FIVE YEARS 1)

2021 ◽  
Vol 4 (2) ◽  
pp. 757-764
Author(s):  
Nayaab Khan ◽  
Lucas Laudermilk ◽  
Jalen Ware ◽  
Taylor Rosa ◽  
Kelly Mathews ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Lesly Nava-Molina ◽  
Toyokazu Uchida-Fuentes ◽  
Héctor Ramos-Tovar ◽  
Martha Fregoso-Padilla ◽  
Marco Aurelio Rodríguez-Monroy ◽  
...  

2020 ◽  
Vol 113 ◽  
pp. 104549 ◽  
Author(s):  
R.J. Newsom ◽  
R.J. Garcia ◽  
J. Stafford ◽  
C. Osterlund ◽  
C.E. O’Neill ◽  
...  

2019 ◽  
Vol 9 (1) ◽  
Author(s):  
Eric W. Fish ◽  
Laura B. Murdaugh ◽  
Chengjin Zhang ◽  
Karen E. Boschen ◽  
Oswald Boa-Amponsem ◽  
...  

Abstract We tested whether cannabinoids (CBs) potentiate alcohol-induced birth defects in mice and zebrafish, and explored the underlying pathogenic mechanisms on Sonic Hedgehog (Shh) signaling. The CBs, Δ9-THC, cannabidiol, HU-210, and CP 55,940 caused alcohol-like effects on craniofacial and brain development, phenocopying Shh mutations. Combined exposure to even low doses of alcohol with THC, HU-210, or CP 55,940 caused a greater incidence of birth defects, particularly of the eyes, than did either treatment alone. Consistent with the hypothesis that these defects are caused by deficient Shh, we found that CBs reduced Shh signaling by inhibiting Smoothened (Smo), while Shh mRNA or a CB1 receptor antagonist attenuated CB-induced birth defects. Proximity ligation experiments identified novel CB1-Smo heteromers, suggesting allosteric CB1-Smo interactions. In addition to raising concerns about the safety of cannabinoid and alcohol exposure during early embryonic development, this study establishes a novel link between two distinct signaling pathways and has widespread implications for development, as well as diseases such as addiction and cancer.


Sign in / Sign up

Export Citation Format

Share Document